Medicare Enrolled

Dr. Steven Hays, M.D.

Nephrology · Dallas, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
411 N WASHINGTON AVE STE 6000, Dallas, TX 75246
2143582300
In practice since 2006 (20 years)
NPI: 1073591566 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hays from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hays? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hays

Dr. Steven Hays is a nephrology specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hays performed 227 Medicare services across 98 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hays received a total of $6,045 from 45 pharmaceutical and/or device companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hays is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 227 Medicare services $6,045 industry payments

Medicare Practice Summary

Medicare Utilization ↗
227
Medicare services
Bottom 9% in TX for nephrology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
98
Unique beneficiaries
$127
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~11 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 161 $66 $175
Dialysis services, 4 or more physician visits per month (20 years or older) 66 $277 $850
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,045
Total received (2018-2024)
Avg $864/year across 7 years
Top 17% in TX for nephrology
45
Companies
294
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,043 (100.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1 (0.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,080
2023
$926
2022
$763
2021
$335
2020
$427
2019
$1,377
2018
$1,137

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,161
Relypsa, Inc.
$557
Otsuka America Pharmaceutical, Inc.
$419
Veloxis Pharmaceuticals, Inc.
$417
Amgen Inc.
$331
OPKO Pharmaceuticals, LLC
$329
Alexion Pharmaceuticals, Inc.
$299
AKEBIA THERAPEUTICS INC
$174
Vifor Pharma, Inc.
$172
Aurinia Pharma U.S., Inc.
$172
Mallinckrodt Hospital Products Inc.
$164
Keryx Biopharmaceuticals, Inc.
$132
Mallinckrodt LLC
$130
La Jolla Pharmaceutical Company
$116
Amicus Therapeutics, Inc.
$108
CALLIDITAS THERAPEUTICS US INC.
$97
GlaxoSmithKline, LLC.
$94
GENZYME CORPORATION
$94
SHIELD THERAPEUTICS INC
$85
Fresenius USA Marketing, Inc.
$69
NxStage Medical, Inc.
$66
Janssen Pharmaceuticals, Inc
$63
Genentech USA, Inc.
$62
Shire North American Group Inc
$62
Bayer Healthcare Pharmaceuticals Inc.
$54
Bayer HealthCare Pharmaceuticals Inc.
$50
NXSTAGE MEDICAL, INC.
$49
Mallinckrodt Enterprises LLC
$48
Novo Nordisk Inc
$45
Takeda Pharmaceuticals U.S.A., Inc.
$41
Horizon Therapeutics plc
$40
Novartis Pharmaceuticals Corporation
$35
Travere Therapeutics, Inc.
$34
Chiesi USA, Inc.
$33
E.R. Squibb & Sons, L.L.C.
$29
ANI Pharmaceuticals, Inc.
$28
Horizon Pharma plc
$27
Alnylam Pharmaceuticals Inc.
$27
Recor Medical Inc
$25
Ardelyx, Inc.
$23
Retrophin, Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Cumberland Pharmaceuticals, Inc.
$19
Maquet Cardiovascular U.S. Sales, L.L.C.
$14
Noden Pharma USA Inc
$12
Top 3 companies account for 35.3% of total payments
Associated products mentioned in payments ›
(815) Thiola · ACCRUFER · ACTHAR · AURYXIA · Auryxia · BENLYSTA · BRILINTA · CLEVIPREX · ELIQUIS · ENVARSUS · Envarsus · Envarsus XR (SP) · FABRAZYME · FABRY-DISEASE · FARXIGA · FLIXENE · GALAFOLD · GATTEX · GIAPREZA · IBSRELA · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LIVTENCITY · LOKELMA · LUPKYNIS · NATPARA (PARATHYROID HORMONE) · NXSTAGE SYSTEM ONE · OXLUMO · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · Rayaldee (old) · Rituxan · Rybelsus · SAMSCA · SOLIRIS · Soliris · System One · TARPEYO · TAVNEOS · TEKTURNA · TERLIVAZ · ULTOMIRIS · Ultomiris · Vaprisol · Velphoro · Veltassa · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2,663 per 100 Medicare services performed
Looking for a nephrology specialist in Dallas?
Compare nephrologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
211
Per 100K population
8.1
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hays is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Hays experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hays performed 161 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hays receive payments from pharmaceutical companies?
Yes. Dr. Hays received a total of $6,045 from 45 companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hays's costs compare to other nephrologists in Dallas?
Dr. Hays's average Medicare payment per service is $127. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hays) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →